This is a Competitive renewal application for the P30-supported Cincinnati Rheumatic Diseases Core Center (CRDCC). The overall goal of the CRDCC is to promote biomedical research that yields insights into fundamental processes and pathogenic mechanisms of rheumatic diseases in children, which can lead to innovative treatments for these diseases.
The aims of the CRDCC are to foster this research and promote interdivisional and interdepartmental collaborations, with a focus on translational opportunities. CRDCC-supported projects have great potential to advance the national research agenda related to rheumatic diseases, and represent an area of tremendous strength and resource investment at Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine. The CRDCC offers four innovative research cores, including Pediatric Rheumatology Tissue Repository Core, Animal Models Core, Integrative Cell Phenotyping and Morphology Core, and Bioinformatics Core. Collectively, these Cores form a powerful infrastructure that fosters development of personalized and predictive medical approaches based on genomics and disease mechanisms. The CRDCC supports disease based research across the continuum of discovery, where laboratory findings generate translational studies that lead to clinical trials. In addition to advancing knowledge of pediatric rheumatic disease, the goals of the CRDCC include recruitment of established investigators to bring new expertise to the field, cultivation of collaborations among Research Base investigators, and encouragement of young investigators committed to pursuing research careers focused on pediatric rheumatic disease. These goals of the CRDCC are particularly supported by a Pilot &Feasibility Study Program that will transcend the Cincinnati Research Base to include pediatric rheumatology investigators across the US. The CRDCC also will improve the Cincinnati Research Base through an enrichment program of local seminars, workshops and symposia. The success of the CRDCC is evidenced by productivity of the Research Base, the extensive scope of ongoing collaborations, and the Research Base's record of receiving funding for cutting edge research related to pediatric rheumatic disease. These past accomplishments are likely to be strongly predictive of the future success of CRDCC-supported research.

Public Health Relevance

The Cincinnati Rheumatic Diseases Core Center will promote biomedical research that yields insights into fundamental processes and pathogenic mechanisms of rheumatic diseases in children. This will be done by coordinating research core services and promoting interdivisional and interdepartmental collaborations.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1-MLB (M1))
Program Officer
Wang, Yan Z
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Olsson, Andre; Venkatasubramanian, Meenakshi; Chaudhri, Viren K et al. (2016) Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537:698-702
Clement, Cristina C; Moncrieffe, Halima; Lele, Aditi et al. (2016) Autoimmune response to transthyretin in juvenile idiopathic arthritis. JCI Insight 1:
Miethke, Alexander G; Zhang, Wujuan; Simmons, Julia et al. (2016) Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice. Hepatology 63:512-23
Engevik, Amy C; Feng, Rui; Choi, Eunyoung et al. (2016) The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged Stomach. Cell Mol Gastroenterol Hepatol 2:605-624
Liu, Ke; Kurien, Biji T; Zimmerman, Sarah L et al. (2016) X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis Rheumatol 68:1290-300
Fecher, Roger A; Horwath, Michael C; Friedrich, Dirk et al. (2016) Inverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatum. J Immunol 197:565-79
Brunner, Hermine I; Bennett, Michael R; Abulaban, Khalid et al. (2016) Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults. Arthritis Care Res (Hoboken) 68:1003-11
Luggen, Michael E; Gulati, Gaurav; Zhang, Bin et al. (2016) Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE. Clin Rheumatol 35:93-9
Klarquist, Jared; Janssen, Edith M (2015) The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice. J Vis Exp :e53319
Carpenter, April C; Smith, April N; Wagner, Heidi et al. (2015) Wnt ligands from the embryonic surface ectoderm regulate 'bimetallic strip' optic cup morphogenesis in mouse. Development 142:972-82

Showing the most recent 10 out of 162 publications